top of page


Advance RI-CTR is a statewide hub of research resources and services for clinical and translational investigators in Rhode Island.
Specialty
Areas
-
Cancer Epidemiology
-
Phase 1 Oncology Tumor Trials
-
GI Cancers
-
Lymphoma
Prioritized Clinical Trial Phases
-
Phase I
-
Phase II
-
Phase III
Trial Activation
Time
- Average turnaround time for Clinical Trial Agreements, Budget Negotiations, and IRB approval is 8 weeks
Site Highlights
-
Active and growing clinical research programs in emergency medicine, stroke/vascular neurology, and cardiology.
​​
-
Extensive experience conducting clinical trials across multiple specialty areas.
​​
- Strong interest and expertise in medical device development and testing.
​
Learn More about Advance RI-CTR
​​
-
To learn more and connect with Advance RI-CTR, contact Andrew Schumacher
bottom of page